Clinical Trial on New Antidepressant Medication for Patients with Depression

Despite numerous treatment options, major depression remains a widespread, debilitating illness. Two-thirds of patients who are initially prescribed antidepressant medications do not experience a timely response to their treatment.

This study is to evaluate the potential benefits of a brand-new drug (EB-1010) in the treatment of depression in patients who have failed an initial course of treatment with other drugs.
 
See if you qualify
Other Useful Links:

What Is TrialReach?

Instant Online Assessment

  • All treatment free of charge
  • 100% Confidential
  • Fully Regulated
  • Everything in plain English
  • Eligibility decision in minutes
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

MoreMore information about this clinical trial